Microbiome Therapeutics prepares to launch first microbiome modulator after completing Series B financing

261828b1-e8b6-4c71-a5dc-0270aa80590barticleimage.jpg

08 Nov 2017 --- MicroBiome Therapeutics, LLC (MBT), a company that applies the science of the gastrointestinal (GI) microbiome to promote health and wellness, has announced the completion of a Series B financing that raised approximately US$1 million. MBT intends to use the proceeds to launch its clinically-tested microbiome modulator product in 2018.

The dietary supplement is specifically designed to balance and optimize the GI tract and promote healthy metabolism by nourishing and nurturing the growth of healthful gut bacteria, MBT notes. New and existing investors include Lagniappe Angels, NO/LA Angel Network, Zehnder Communications and other private investors.

“We appreciate the support of our investors, which will enable the planned launch of our lead microbiome modulator next year,” says Dale Pfost, Acting CEO of MBT. “This product is a scientific formulation of natural ingredients designed to support a balanced GI microbiome and promote metabolic health in an easy-to-use, flavorful drink mix.”

“Our two clinical trials, conducted at the Pennington Biomedical Research Center and reported in peer-reviewed publications, demonstrated its benefits in helping to manage hunger, maintain healthy blood sugar levels and promote regularity,” Pfost adds.

The product is described as an all-natural blend of prebiotics, including fermentable fiber and polyphenol antioxidants in a patent-pending blend intended to help nurture and nourish beneficial microorganisms in the lower gut.

MBT reports that the launch of its microbiome modulator will be supported by a two-year e-commerce and social media campaign conducted in partnership with New Orleans-based advertising agency Zehnder Communications. MBT is also assembling a nationwide network of registered dietitians and certified diabetic educators to support the launch.

“With MicroBiome Therapeutics, we saw a unique opportunity to apply our product launch expertise in support of an exciting, first-in-class product from a leading science-based company,” says Jeremy Hunnewell, CFO and Business Strategist for Zehnder Communications. “We believe our expertise, along with our integrative and analytical approaches, will enable MBT to inform and educate consumers about this exciting new type of health-promoting dietary supplement.”

“Our investment reinforces our commitment to making a difference by playing a part in the microbiome revolution,” states Hunnewell, who will be joining the board of directors of MBT.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Health Logics launches mood and cognition-enhancing supplement

16 Nov 2018 --- Health Logics is launching a dietary supplement containing S-adenosylmethionine. Also known as SAM-e, produced by advanced biotech company Gnosis, the ingredient is touted as improving joint, brain and liver function, and enhances mood and cognition.

Health & Nutrition News

Navigating the digestive health space: Probiotic strain specificity and microbiome key to future NPD

16 Nov 2018 --- Emerging science linking a healthy microbiome to nearly every facet of health, as well as the ongoing media reporting on probiotics, have helped drive consumer interest in gut health. This growing area offers a wealth of opportunities to formulators, but due to regulatory demands and increasing consumer scrutiny, a clear view of how to navigate this space is vital.

Health & Nutrition News

Weekly Roundup: DSM enters Japanese partnership on healthy aging, Croda expands with Marine Biotechnology innovation center

16 Nov 2018 --- In nutrition news this week, Croda opened a new Center of Innovation for Marine Biotechnology and DSM entered a collaboration on the development of services in nutritional rehabilitation and disease prevention in Japan. Lonza and Sartorius Stedim Biotech (SSB) are modifying their current agreement for the supply of cell culture media by mutual accord. Lastly, Gelita recently hosted a US symposium called, “The Sounds of Health and Nutrition,” which aimed to offer inspiration for market opportunities in the global health and nutrition marketplace.

Health & Nutrition News

Kellogg’s debuts gut-boosting cereal with prebiotics, probiotics and fiber

15 Nov 2018 --- Kellogg’s has launched a “3-in-1” cereal aimed at making digestive wellness support easily accessible in food. The new wellness brand HI! Happy Inside delivers prebiotics, probiotics and fiber in an all-in-one cereal. The launch comes at a time when interest in digestive health seems to only continue to grow.

Health & Nutrition News

Cranberries found to reduce negative effects of animal-based diet on gut health

15 Nov 2018 --- A Cranberry Institute and USDA-funded study into the potential protective effects of cranberries on the gut microbiome has found that adding cranberries to a meat-based diet can reduce the rise in secondary gut bile acids that have been associated with colon and GI cancer. The feeding trial – published in The Journal of Nutritional Biochemistry – found that the addition of whole cranberry powder to this common diet lessened potentially carcinogenic secondary bile acids and blunted the decline in beneficial short-chain fatty acids (SCFA) in the gastrointestinal (GI) tract.

More Articles
URL : http://www.nutritioninsight.com:80/news/microbiome-therapeutics-prepares-to-launch-first-microbiome-modulator-after-completing-series-b-financing.html